| Kevin D Thomas, MD | |
|
203 S Candy Ln Ste 13ab, Cottonwood, AZ 86326-4120 | |
| (928) 649-1389 | |
| (928) 634-5314 |
| Full Name | Kevin D Thomas |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 33 Years |
| Location | 203 S Candy Ln Ste 13ab, Cottonwood, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730143637 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 34450 (Wyoming) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yavapai Regional Medical Center | Prescott, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Doc Martins Inc A C C | 6608867197 | 14 |
News Archive
Laboratoires Thea, the leading independent ophthalmic group in Europe, completes its innovative product range with the announcement of the final acquisition of Mydriasert(R). Mydriasert(R), the 1st mydriatic ophthalmic insert, is indicated for dilated fundus examination (DFE) or cataract surgery, the most widely implemented surgical procedure. Regarding cataract surgery, the market represents close to 300 000 procedures in the UK and Ireland and 3 million in Europe each year.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Nifedipine Extended-release Tablets USP, 30 mg, 60 mg and 90 mg, the generic version of Pfizer's Procardia XL® Tablets, a treatment for angina and/or hypertension.
Sleep apnea is commonly diagnosed by way of measuring airflow by nasal pressure, temperature, and/or carbon dioxide, through sensors placed in the nose.
Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory diseases, today announced that it has been awarded a grant for $5.7 million from the Defense Advanced Research Projects Agency (DARPA), a component of the Department of Defense (DOD), focused on identifying and advancing novel technologies to support defense of our nation's soldiers and civilian population.
Medtronic, Inc. today announced it has received CE Mark for the Medtronic CoreValve System to be delivered using direct aortic access.
› Verified 9 days ago
| Entity Name | Doc Martins Inc A C C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699724039 PECOS PAC ID: 6608867197 Enrollment ID: O20040522000252 |
News Archive
Laboratoires Thea, the leading independent ophthalmic group in Europe, completes its innovative product range with the announcement of the final acquisition of Mydriasert(R). Mydriasert(R), the 1st mydriatic ophthalmic insert, is indicated for dilated fundus examination (DFE) or cataract surgery, the most widely implemented surgical procedure. Regarding cataract surgery, the market represents close to 300 000 procedures in the UK and Ireland and 3 million in Europe each year.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Nifedipine Extended-release Tablets USP, 30 mg, 60 mg and 90 mg, the generic version of Pfizer's Procardia XL® Tablets, a treatment for angina and/or hypertension.
Sleep apnea is commonly diagnosed by way of measuring airflow by nasal pressure, temperature, and/or carbon dioxide, through sensors placed in the nose.
Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory diseases, today announced that it has been awarded a grant for $5.7 million from the Defense Advanced Research Projects Agency (DARPA), a component of the Department of Defense (DOD), focused on identifying and advancing novel technologies to support defense of our nation's soldiers and civilian population.
Medtronic, Inc. today announced it has received CE Mark for the Medtronic CoreValve System to be delivered using direct aortic access.
› Verified 9 days ago
| Entity Name | Susan Albright Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851478333 PECOS PAC ID: 0547269458 Enrollment ID: O20061204000078 |
News Archive
Laboratoires Thea, the leading independent ophthalmic group in Europe, completes its innovative product range with the announcement of the final acquisition of Mydriasert(R). Mydriasert(R), the 1st mydriatic ophthalmic insert, is indicated for dilated fundus examination (DFE) or cataract surgery, the most widely implemented surgical procedure. Regarding cataract surgery, the market represents close to 300 000 procedures in the UK and Ireland and 3 million in Europe each year.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Nifedipine Extended-release Tablets USP, 30 mg, 60 mg and 90 mg, the generic version of Pfizer's Procardia XL® Tablets, a treatment for angina and/or hypertension.
Sleep apnea is commonly diagnosed by way of measuring airflow by nasal pressure, temperature, and/or carbon dioxide, through sensors placed in the nose.
Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory diseases, today announced that it has been awarded a grant for $5.7 million from the Defense Advanced Research Projects Agency (DARPA), a component of the Department of Defense (DOD), focused on identifying and advancing novel technologies to support defense of our nation's soldiers and civilian population.
Medtronic, Inc. today announced it has received CE Mark for the Medtronic CoreValve System to be delivered using direct aortic access.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kevin D Thomas, MD Po Box 5127, Everett, WA 98206-5127 Ph: (425) 258-3900 | Kevin D Thomas, MD 203 S Candy Ln Ste 13ab, Cottonwood, AZ 86326-4120 Ph: (928) 649-1389 |
News Archive
Laboratoires Thea, the leading independent ophthalmic group in Europe, completes its innovative product range with the announcement of the final acquisition of Mydriasert(R). Mydriasert(R), the 1st mydriatic ophthalmic insert, is indicated for dilated fundus examination (DFE) or cataract surgery, the most widely implemented surgical procedure. Regarding cataract surgery, the market represents close to 300 000 procedures in the UK and Ireland and 3 million in Europe each year.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Nifedipine Extended-release Tablets USP, 30 mg, 60 mg and 90 mg, the generic version of Pfizer's Procardia XL® Tablets, a treatment for angina and/or hypertension.
Sleep apnea is commonly diagnosed by way of measuring airflow by nasal pressure, temperature, and/or carbon dioxide, through sensors placed in the nose.
Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory diseases, today announced that it has been awarded a grant for $5.7 million from the Defense Advanced Research Projects Agency (DARPA), a component of the Department of Defense (DOD), focused on identifying and advancing novel technologies to support defense of our nation's soldiers and civilian population.
Medtronic, Inc. today announced it has received CE Mark for the Medtronic CoreValve System to be delivered using direct aortic access.
› Verified 9 days ago
Elena Suzanne Shea, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 S Willard St Ste 103, Cottonwood, AZ 86326 Phone: 928-634-9573 Fax: 928-634-0135 | |
Laurel A Mueller, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 51 Brian Mickelsen Pkwy, Community Health Center Of Yavapai, Cottonwood, AZ 86326 Phone: 928-639-8132 | |
Donald E Stephens Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 340 S Willard St, Cottonwood, AZ 86326 Phone: 928-639-6025 Fax: 928-634-5604 | |
Patricia Anne Smith, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 340 S Willard St, Cottonwood, AZ 86326 Phone: 928-639-6025 | |
Marvin L Colvin, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 753 N Main St, Ste. A, Cottonwood, AZ 86326 Phone: 928-634-7470 Fax: 928-639-3280 | |
Dr. Henry H Kaldenbaugh, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 214 S Main St, Cottonwood, AZ 86326 Phone: 928-634-7534 | |
Mary F. Sutter, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 51 S Brian Mickelsen Pkwy, Cottonwood, AZ 86326 Phone: 928-634-6828 Fax: 928-639-8179 |